Unlocking Blood Drivers of Neurodegeneration: Mechanisms and therapies
Thus, fibrinogen links cerebrovascular damage with immune-mediated neurodegeneration and fibrin therapeutics may have important therapeutic implications inhibiting vascular-driven neurodegeneration in AD and related conditions. References 1. Mendiola et al. Nat Immunol 2023, 24:1173-1187 2. Ryu et al. Nat Immunol 2018, 19:1212-1223 3. Petersen et al., Nat Rev Neurosci. 2018, 19:283-301 4. Merlini et al. Neuron 2019, 101:1099-1108.
Authors
- Katerina Akassoglou (ORCID: https://orcid.org/0000-0002-2632-1465)
Institutions
- Gladstone Institutes (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/alz.083655
- Primary Topic
- Neurological diseases and metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00